The Scotts Miracle-Gro Company (FRA:SCQA)
48.44
+0.12 (0.25%)
At close: Nov 28, 2025
FRA:SCQA Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2016 - 2020 |
| 3,413 | 3,553 | 3,551 | 3,924 | 4,925 | Upgrade | |
Revenue Growth (YoY) | -3.93% | 0.04% | -9.50% | -20.32% | 19.20% | Upgrade |
Cost of Revenue | 2,349 | 2,619 | 2,708 | 2,891 | 3,431 | Upgrade |
Gross Profit | 1,065 | 934 | 843 | 1,033 | 1,494 | Upgrade |
Selling, General & Admin | 603.4 | 559 | 551.3 | 613 | 669 | Upgrade |
Research & Development | - | - | - | - | 45.4 | Upgrade |
Amortization of Goodwill & Intangibles | - | - | - | - | 29.1 | Upgrade |
Other Operating Expenses | 18.4 | 10.3 | -0.1 | 0.8 | -1.8 | Upgrade |
Operating Expenses | 621.8 | 569.3 | 551.2 | 613.8 | 741.7 | Upgrade |
Operating Income | 442.7 | 364.7 | 291.8 | 419.3 | 752 | Upgrade |
Interest Expense | -128.8 | -158.8 | -178.1 | -118.1 | -78.9 | Upgrade |
Interest & Investment Income | - | - | - | - | 4.1 | Upgrade |
Earnings From Equity Investments | -2.8 | -68.1 | -101.1 | -12.9 | 14.4 | Upgrade |
Currency Exchange Gain (Loss) | -0.3 | -9.6 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -5.3 | -5.5 | 0.3 | 6.9 | 2 | Upgrade |
EBT Excluding Unusual Items | 305.5 | 122.7 | 12.9 | 295.2 | 693.6 | Upgrade |
Merger & Restructuring Charges | -47.1 | -68.6 | -199.7 | -184.5 | 0.2 | Upgrade |
Impairment of Goodwill | - | -2.5 | -10.3 | -522.4 | - | Upgrade |
Gain (Loss) on Sale of Investments | -7 | -64.6 | -101.3 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -17.7 | - | - | 16.2 | - | Upgrade |
Asset Writedown | -12 | -10.6 | -154.9 | -162.6 | - | Upgrade |
Other Unusual Items | - | - | - | - | -16.7 | Upgrade |
Pretax Income | 221.7 | -23.6 | -453.3 | -558.1 | 677.1 | Upgrade |
Income Tax Expense | 76.5 | 11.3 | -73.2 | -120.6 | 159.8 | Upgrade |
Earnings From Continuing Operations | 145.2 | -34.9 | -380.1 | -437.5 | 517.3 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | -3.9 | Upgrade |
Net Income to Company | 145.2 | -34.9 | -380.1 | -437.5 | 513.4 | Upgrade |
Minority Interest in Earnings | - | - | - | - | -0.9 | Upgrade |
Net Income | 145.2 | -34.9 | -380.1 | -437.5 | 512.5 | Upgrade |
Net Income to Common | 145.2 | -34.9 | -380.1 | -437.5 | 512.5 | Upgrade |
Net Income Growth | - | - | - | - | 32.29% | Upgrade |
Shares Outstanding (Basic) | 58 | 57 | 56 | 56 | 56 | Upgrade |
Shares Outstanding (Diluted) | 59 | 57 | 56 | 56 | 57 | Upgrade |
Shares Change (YoY) | 3.35% | 1.43% | 0.90% | -2.97% | 0.53% | Upgrade |
EPS (Basic) | 2.52 | -0.61 | -6.79 | -7.88 | 9.20 | Upgrade |
EPS (Diluted) | 2.47 | -0.61 | -6.79 | -7.88 | 8.96 | Upgrade |
EPS Growth | - | - | - | - | 31.60% | Upgrade |
Free Cash Flow | 273.9 | 583.5 | 438.2 | -242.5 | 164.6 | Upgrade |
Free Cash Flow Per Share | 4.67 | 10.27 | 7.83 | -4.37 | 2.88 | Upgrade |
Dividend Per Share | 2.640 | 2.640 | 2.640 | 2.640 | 2.520 | Upgrade |
Dividend Growth | - | - | - | 4.76% | 6.78% | Upgrade |
Gross Margin | 31.19% | 26.29% | 23.74% | 26.33% | 30.33% | Upgrade |
Operating Margin | 12.97% | 10.27% | 8.22% | 10.69% | 15.27% | Upgrade |
Profit Margin | 4.25% | -0.98% | -10.70% | -11.15% | 10.41% | Upgrade |
Free Cash Flow Margin | 8.03% | 16.42% | 12.34% | -6.18% | 3.34% | Upgrade |
EBITDA | 517.7 | 445.3 | 384.3 | 524.5 | 845.8 | Upgrade |
EBITDA Margin | 15.17% | 12.53% | 10.82% | 13.37% | 17.17% | Upgrade |
D&A For EBITDA | 75 | 80.6 | 92.5 | 105.2 | 93.8 | Upgrade |
EBIT | 442.7 | 364.7 | 291.8 | 419.3 | 752 | Upgrade |
EBIT Margin | 12.97% | 10.27% | 8.22% | 10.69% | 15.27% | Upgrade |
Effective Tax Rate | 34.51% | - | - | - | 23.60% | Upgrade |
Advertising Expenses | 152.3 | 141 | 123.7 | 120.3 | 165.7 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.